Quick Takeaways
- B Group, Inc. filed SCHEDULE 13G for NRx Pharmaceuticals, Inc. Common Stock, $0.001 par value (NRXP).
- Disclosed ownership: 13%.
- Date of event: 18 Aug 2025.
B Group, Inc. - 18 Aug 2025 SCHEDULE 13G Report for NRx Pharmaceuticals, Inc. Common Stock, $0.001 par value (NRXP)
- Filing Manager
- B Group, Inc.
- Reporting Manager
- The B Group, Inc.
- Symbol
- NRXP
- Shares outstanding
- 23,771,791 shares
- Disclosed Ownership
- 3,000,000 shares
- Ownership
- 13%
- Form type
- SCHEDULE 13G
- Filing time
- 21 Aug 2025, 06:42:44 UTC
- Date of event
- 18 Aug 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"B Group, Inc. disclosed 13% ownership in NRx Pharmaceuticals, Inc. Common Stock, $0.001 par value (NRXP) on 18 Aug 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 21 Aug 2025, 06:42.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| The B Group, Inc. | 13% | 3,000,000 | 0 | 3,000,000 | /s/ Branden B. Muhl | Branden B. Muhl/Chief Executive Officer | |
| B Group Capital LLC | 13% | 3,000,000 | 0 | 3,000,000 | /s/ Branden B. Muhl | Branden B. Muhl/Manager | |
| Branden B. Muhl | 13% | 3,000,000 | 0 | 3,000,000 | /s/ Branden B. Muhl | Branden B. Muhl |